Edition:
India

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

84.88USD
23 May 2018
Change (% chg)

$0.50 (+0.59%)
Prev Close
$84.38
Open
$84.24
Day's High
$85.00
Day's Low
$83.75
Volume
438,246
Avg. Vol
715,941
52-wk High
$86.38
52-wk Low
$59.64

Latest Key Developments (Source: Significant Developments)

Zoetis Says Upon Deal Termination By Abaxis Or Co, Termination Fee Of $70 Mln May Be Payable By Abaxis
Wednesday, 16 May 2018 

May 16 (Reuters) - Abaxis Inc ::ZOETIS SAYS UPON DEAL TERMINATION BY ABAXIS OR CO, TERMINATION FEE OF $70 MILLION MAY BE PAYABLE BY ABAXIS - SEC FILING.  Full Article

Zoetis To Acquire Abaxis for about $2 Bln In Aggregate
Wednesday, 16 May 2018 

May 16 (Reuters) - Zoetis Inc ::ZOETIS TO ACQUIRE ABAXIS, A LEADING GLOBAL PROVIDER OF VETERINARY POINT-OF-CARE DIAGNOSTIC INSTRUMENTS.ZOETIS INC - PURCHASE PRICE OF DEAL WAS $83 PER SHARE IN CASH, OR APPROXIMATELY $2.0 BILLION IN AGGREGATE.ZOETIS INC - EXPECTS TRANSACTION TO BE ACCRETIVE TO EARNINGS IN 2019.ZOETIS INC - INTENDS TO FUND PURCHASE THROUGH A COMBINATION OF EXISTING CASH AND NEW DEBT.ZOETIS - EXPECTS DEAL TO HAVE IMPACT ON 2018 EARNINGS RELATED TO CUSTOMARY CLOSING ACTIVITIES; ON ADJUSTED BASIS, CO DOES NOT EXPECT MATERIAL IMPACT.  Full Article

Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Zoetis Inc ::ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 .  Full Article

Zoetis Board Approves 20% Dividend Increase
Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - Zoetis Inc ::ZOETIS DECLARES FIRST QUARTER 2018 DIVIDEND; BOARD APPROVES 20% PAYMENT INCREASE.ZOETIS - BOARD DECLARED Q1 2018 DIVIDEND PAYABLE TO HOLDERS OF CO'S COMMON STOCK OF $0.126 PER SHARE, UP 20% FROM QTRLY DIVIDEND RATE PAID IN 2017.  Full Article

Nippon Soda to buy plant health business from Zoetis Japan
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Nippon Soda Co Ltd <4041.T>:Says it will complete acquisition of plant health business from Zoetis Japan, which is engaged in manufacture and sale of veterinary drugs, feed additives and agricultural drugs, in late March, 2018.Price not disclosed .  Full Article

Zoetis Inc Q3 earnings per share $0.61
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Zoetis Inc :Zoetis announces third quarter 2017 results.Q3 adjusted earnings per share $0.65.Q3 earnings per share $0.61.Q3 revenue $1.3 billion versus i/b/e/s view $1.32 billion.Sees FY 2017 earnings per share $2.16 to $2.23.Sees FY 2017 revenue $5.225 billion to $5.275 billion.Sees FY 2017 adjusted earnings per share $2.34 to $2.39.Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $2.34, revenue view $5.20 billion -- Thomson Reuters I/B/E/S.  Full Article

Valeant appoints Paul Herendeen as chief financial officer
Monday, 22 Aug 2016 

Valeant Pharmaceuticals International Inc : Valeant pharmaceuticals appoints Paul S. Herendeen as executive vice president, finance and chief financial officer . Herendeen will take over role of chief financial officer from Robert L. Rosiello effective immediately . Prior to joining Valeant, Herendeen served as executive vice president and chief financial officer of Zoetis Inc. For two years .Rosiello will assume responsibility for corporate development and strategy and continues as evp and an executive committee member.  Full Article

Zoetis appoints Glenn David as CFO
Monday, 22 Aug 2016 

Zoetis Inc : Zoetis announces appointment of Glenn David as executive vice president and chief financial officer . Glenn David, senior vice president of finance operations, has been named executive vice president and chief financial officer .Glenn david will succeed CFO paul herendeen, who has resigned effective august 18, 2016, to accept position of CFO at another public co.  Full Article

Pershing Square Capital Management cuts share stake in Zoetis by 49 pct
Tuesday, 16 Aug 2016 

Zoetis Inc :Pershing Square Capital Management cuts share stake in Zoetis by 49 percent to 21.1 million shares - SEC filing.  Full Article

Zoetis acquires Scandinavian Micro Biodevices to extend pipeline in veterinary diagnostics
Monday, 8 Aug 2016 

Zoetis Inc : Deal for $80 million . Zoetis acquires scandinavian micro biodevices to extend its pipeline in diagnostics for veterinary use .Deal for $80 million.  Full Article

Photo

Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion

Top animal health company Zoetis Inc will buy Abaxis Inc for $1.9 billion, looking to capture a bigger slice of the fast-growing market for diagnostics services that cater to household pets and farm animals.